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JoBackground: Hypertension, even during childhood,
increases the risk of developing atherosclerosis and
cardiovascular disease. Therefore, starting prevention of
hypertension early in the life course could be beneficial.
Prediction models might be useful for identifying children at
increased risk of developing hypertension, which may enable
targeted primordial prevention of cardiovascular disease.
Objective: To provide an overview of childhood prediction
models for future hypertension.
Methods: Embase and Medline were systematically
searched. Studies were included that were performed in
the general population, and that reported on development
or validation of a multivariable model for children to
predict future high blood pressure, prehypertension or
hypertension. Data were extracted using the CHARMS
checklist for prediction modelling studies.
Results: Out of 12780 reviewed records, six studies were
included in which 18 models were presented. Five studies
predicted adulthood hypertension, and one predicted
adolescent prehypertension/hypertension. BMI and current
blood pressure were most commonly included as
predictors in the final models. Considerable heterogeneity
existed in timing of prediction (from early childhood to late
adolescence) and outcome measurement. Important
methodological information was often missing, and in four
studies information to apply the model in new individuals
was insufficient. Reported area under the ROC curves
ranged from 0.51 to 0.74. As none of the models were
validated, generalizability could not be confirmed.
Conclusion: Several childhood prediction models for
future hypertension were identified, but their value for
practice remains unclear because of suboptimal methods,
limited information on performance, or the lack of external
validation. Further validation studies are indicated.
Keywords: adolescents, blood pressure, children,
hypertension, prediction, review, risk assessment
Abbreviations: AUC, area under the ROC curve; BP,
blood pressure; CHAID, chi-square automatic interaction
detection; CHARMS, Checklist for Critical Appraisal and
Data Extraction for Systematic Reviews of Prediction
Modelling Studies; CI, confidence interval; CRP, C-reactive
protein; C-statistic, concordance statistic; CVD,
cardiovascular disease; HDL, high-density lipoprotein; IDI,
integrative discrimination index; IOTF, International Obesityurnal of HypertensionTask Force; LDL, low-density lipoprotein; NA, not
applicable; NPV, negative predictive value; NR, not
reported; NRI, net reclassification improvement index; OR,
odds ratio; PPV, positive predictive value; PRISMA,
Preferred Reporting Items for Systematic Reviews and
Meta-Analysis; ROC, receiver operating characteristic; SD,
standard deviation; TRIPOD, Transparent Reporting of a
Multivariable Prediction Model for Individual Prognosis or
DiagnosisINTRODUCTIONA
dulthood hypertension is a very common and estab-
lished risk factor for cardiovascular disease (CVD)
[1]. There is increasing evidence that adulthood
hypertension and CVD originate in early life; risk factors
such as overweight, lipid abnormalities, and high blood
pressure are prevalent in children, and the process of
atherosclerosis can already be observed in childhood [2].
For example, in autopsy studies, childhood high blood
pressure has been associated with atherosclerosis in the
coronary arteries and the aorta [2–4]. It has also been
associated with unfavorable changes in markers of subclin-
ical atherosclerosis in adulthood such as increased carotid
intima-media thickness and coronary artery calcification,
independently of adulthood blood pressure [5,6].
Considering the above, and given that average blood
pressure levels in children have increased over recent
decades (largely driven by the rising levels of childhood
overweight and obesity) [2,7], primordial prevention of
CVD by preventing the development of hypertension isDOI:10.1097/HJH.0000000000001970
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Hamoen et al.becoming increasingly relevant. This is also reflected
in guidelines by American and European medical organiza-
tions that underline the importanceof startingprimordial and
primary prevention of CVD early in the life course [8–10].
Strategies for preventing hypertension, for example
aimed at improving nutrition and increasing physical activ-
ity [2], might be especially effective if targeted to individual
children at an increased risk of developing hypertension. As
blood pressure tracks into adulthood [11], current blood
pressure values might be useful to identify these high-risk
children. Other characteristics, such as BMI or the presence
of parental hypertension, may also be useful in the predic-
tion of future hypertension. With this systematic review, we
aimed to provide an overview of predictionmodels that aim
to identify children at increased risk for future hyperten-
sion, which could enable targeted primordial prevention.
METHODS
This systematic review is reported in accordance with
recommendations as presented in the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis (PRISMA)
statement [12]. The protocol for this systematic review has
been published on PROSPERO, and is available at http://
www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=
CRD42015027446.
Search strategy
A systematic literature search was conducted in Embase and
Medline in July 2015, with the support of an information
specialist, and was updated in March 2018. The search
included synonyms for the terms: high blood pressure or
prehypertension or hypertension, prediction model, and
children. The complete search syntaxes for the different
databases can be found in Supplemental Table 1, http://
links.lww.com/HJH/B32. Additionally, the references of
the included studies were hand searched.
Study selection
We included original studies that were performed in the
general population, and that reported on the development
or validation of a multivariable prediction model, to esti-
mate in childhood or adolescence, the risk of high blood
pressure, prehypertension or hypertension later in life. We
considered as multivariable prediction models those based
on two or more variables, where we counted stratification
by sex also as a variable. In case more than one multivari-
able prediction model was presented in a study, character-
istics on all of the eligible prediction models were extracted
for the purpose of this review. Studies not focused on the
development or validation of a prediction model, for exam-
ple studies aimed at predictor finding or tracking, were
excluded for this review. Also, we excluded studies with the
outcome defined as either high SBP or high DBP, as the
internationally accepted definitions of high blood pressure,
prehypertension, and hypertension combine both SBP and
DBP [13,14]. Abstracts from conference proceedings, edi-
torials and reviews were excluded as well, and language
was restricted to English.
After removing the duplicates, one reviewer (M.H.)
screened all titles and abstracts according to the predefined866 www.jhypertension.cominclusion and exclusion criteria. A second and third
reviewer (M.K. and Y.V.) each checked half of a 10%
random sample of these titles and abstracts to see if results
corresponded. Full texts of eligible articles were retrieved
and assessed by twomembers of the review team (M.H. and
M.K.). Any discrepancies between the two reviewers were
managed by consensus discussion. In case of no consensus,
the opinion of a third reviewer (Y.V.) was decisive.
Data extraction and evaluation
Data were extracted from the articles using a standardized
data extraction form based on the Checklist for Critical
Appraisal and Data Extraction for Systematic Reviews of
Prediction Modelling Studies (CHARMS) [15]. Extraction
was done independently by two reviewers (M.H. and
M.W.). Lack of clarity during the extraction process was
resolved by consulting a third reviewer (M.K. or Y.V.).
If questions remained, an attempt was made to contact
the corresponding author, first author or last author by
e-mail; in case of no response the e-mail was sent one
more time.
On the basis of the completed CHARMS checklist, two
reviewers (M.H. and M.W.) summarized and critically
appraised the following elements for each study: study
design, study population, measurement and definition of
outcome and predictors, time interval between prediction
and outcome, sample size, number of events, handling of
missing data, modelling method, validation method, model
performance (discrimination, calibration, explained varia-
tion), and model presentation. As there is not yet a formal
risk of bias score for prediction modelling studies, we
performed a risk of bias assessment using criteria that we
adapted from a systematic review on asthma prediction
models by Smit et al. [16], which were in turn derived from
the CHARMS checklist [15]. Our criteria are described in
Supplemental Table 2, http://links.lww.com/HJH/B32.
Both reviewers (M.H. and M.W.) independently assessed
the following aspects: selection bias (selection of partic-
ipants and sample attrition), information bias (predictors
and outcome) and bias related to the analysis. In case of
disagreement, results were discussed until consensus was
reached. For each item, the risk of bias was then classified as
low, moderate, or high.
RESULTS
Study selection
With the systematic literature search, 12 780 unique refer-
enceswere found,whichwere screenedon title and abstract.
The agreement between the first and second or third
reviewer (M.H. andM.K. or Y.V.) for the random10% sample
was higher than 99.5%. The first reviewer (M.H.) included
four references that the second or third reviewer did not
include; after consensus discussions these references were
not considered relevant for this review. Next, 78 references
were considered for the full text screening. From these
references, six studies satisfied the inclusion criteria and
were selected for this review (Fig. 1). Each study presented
multiple prediction models that could be included in this
review, ranging from two to four models per study, and a
total of eighteen models that are discussed in this review.Volume 37  Number 5  May 2019
EMBASE 
9592 
Removal of duplicates 
4855
12780 screened on title/abstract 
Excluded after title/abstract screening 
12700  
MEDLINE 
8043 
80 screened on full text 
Excluded after full text screening 
10 reviews 
1 non-English language 
8 not about prediction of high BP 
10 not in general population/not in 
children 
5 not longitudinal 
32 not focusing on developing a 
prediction model 
7 prediction model(s) based on only a 
single predictor 
1 not assessing high BP as a combination 
of SBP and DBP 
6 studies included  
Additional 
references from 
relevant reviews and 
included studies 
0
FIGURE 1 Flowchart of selection process. BP, blood pressure.
Predicting hypertension: a reviewStudy aims
Although in each study multivariable prediction models
were developed, we noticed that in none of the studies it
was part of the study aim(s) to show how the model could
be translated into practice. Study aims were more generally
formulated, for example as ‘examining the predictive utility
of certain predictors’ or ‘examining the best combinations
of predictors.’ The study aims of the included studies are
presented in Table 1.
Study designs and populations
Table 1 shows key characteristics of the six included stud-
ies. The study results were published between 2003 and
2015, and the studies were conducted in five different
countries (Cuba [17], Finland [18,19], Netherlands [20],
United Kingdom [21], and United States [22]). All studies
were based on cohorts with longitudinal data; five were
prospective cohort studies [17–19,21], and one was a ret-
rospective cohort study [20].
There was variation between studies with regard to study
population characteristics such as age and ethnicity. For age
at time of prediction, two studies specifically examined
adolescents around the age of 13 years [17,20]. In the other
studies, predictors were measured in both children and
adolescents, with wider age ranges: 3–18 years [19], 5–17
years [22], 6–18 years [18], and 7–17 years [21]. With regard
to ethnicity, two of the included studies were performed in
the Cardiovascular Risk in Young Finns Study, in which
only children from white European ethnicity were includedJournal of Hypertension[18,19]. One study included mostly non-Hispanic whites
[22]. In three of the studies, ethnicity was not reported
[17,20,21].
In one study, it was unclear how the cohort was recruited
exactly [17]. In another study, it was not clear how the
sample for analysis was selected from the original cohort
[22]. In three studies, information on the distribution of
predictors was lacking [17,18,22]. In the five prospective
studies, there was loss to follow-up ranging from 8 to 45%;
in two of these studies, there was no clear comparison of
key characteristics between responders and nonresponders
[17,22], and in three of these studies some significant differ-
ences in key characteristics between responders and non-
responders were found, for example in sex, age or
socioeconomic status [18,19,21].
Definition of hypertension
The outcome definitions in each study are summarized
in Table 1 (more details in Supplemental Table 3, http://
links.lww.com/HJH/B32). Five studies predicted adulthood
hypertension, which in three studies was defined as SBP at
least 140mmHg and/or DBP at least 90mmHg, or the use of
antihypertensive medication [18,20,21]. In one study, it was
defined as SBP at least 130mmHg and/or DBP at least
85mmHg, or the use of antihypertensive medication [19].
In another study, the outcome was defined as the first
appearance of hypertension (>130/85mmHg) at or after
the age of 30 years [22], however, it remained unclear how a
first appearance of hypertension occurring before the agewww.jhypertension.com 867
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Predicting hypertension: a review
Journal of Hypertensionof 30 years was handled (study participants were aged
20 years or older).
One study predicted adolescent prehypertension
(including hypertension) at the age of 16–19 years. For
children aged 16–18 years, this was defined as SBP and/or
DBP at least 90th percentile (for sex, age and height), or SBP
at least 120mmHg and/or DBP at least 80mmHg. For those
aged 19 years, percentiles were not used and prehyperten-
sion was defined as SBP and/or DBP at least 120/80mmHg
[17].
In all studies, multiple measurements of blood pressure
were performed, and in five studies it was clear that average
SBP and DBP values were used to assess the presence of
hypertension. In one study, an average based on the last
two out of three measurements was used [22], in three
studies, the average of all three measurements was used
[18,19,21], and in one study the average of four measure-
ments, spread over two visits, was used [20]. Ferrer et al.[17]
reported to have performed repeated measurements at
5-min intervals, but did not report the number of measure-
ments, and if averages were calculated or not. Use of
antihypertensive medication was self-reported in all studies
that included this in the outcome [18–21].
Predictors
In Table 2 the candidate predictors and final predictors
of the models are shown (more detail on definition and
measurement can be found in Supplemental Table 3, http://
links.lww.com/HJH/B32).
In three studies, a fixed set of predictors was chosen a
priori, meaning that there was no selection from a broader
range of candidate predictors; this choice was related to the
specific aim(s) of each study [18,21,22]. For example, one
study investigated the usefulness of childhood levels of
cardiovascular risk factors (i.e. definitions of childhood
overweight, obesity, prehypertension/hypertension, dysli-
pidemia) for predicting the adulthood risk factor levels,
separately for boys and girls [18]. Similarly, another study
aimed to establish criterion values for childhood blood
pressure to predict hypertension in later life, which were
then combined in a model with BMI and age [22]. The third
study aimed to establish how well different cut-offs for
BMI and BMI gain in childhood predict hypertension in
adulthood [21]. In three studies a selection from multiple
candidate predictors was made to obtain the final models
[17,19,20].
In most studies, continuous variables were categorized
[17–19,21,22]. This was inherent to the aims in three of
these studies, as described in the previous paragraph
[18,21,22], but not in the other two studies [17,19].
Childhood overweight was considered as a predictor in
three studies [17,19,21], and was a predictor in final models
in two of these [19,21]. BMI was a predictor in three studies
[17,20,22]. In two of these, BMI was not selected in all of the
final models, for example not in the models stratified for
girls and boys [20], and not in the model for girls [17].
Childhood high blood pressure or high SBP was consid-
ered as a predictor in four studies [17–20]. In two of those
studies, it was the main predictor of interest [18,22]. In the
other two, it was a candidate predictor before the selection
procedure [17,19], and it ended up in the final model in onewww.jhypertension.com 869
T
A
B
LE
2
.
C
h
a
ra
ct
e
ri
st
ic
s
o
f
th
e
in
cl
u
d
e
d
p
re
d
ic
ti
o
n
m
o
d
e
ls
a
(C
a
n
d
id
a
te
)
p
re
d
ic
to
rs
A
u
th
o
r
(y
e
a
r)
M
o
d
e
ll
in
g
m
e
th
o
d
a
n
d
m
e
th
o
d
fo
r
se
le
ct
io
n
o
f
p
re
d
ic
to
rs
M
o
d
e
ls
O
v
e
rw
e
ig
h
t/
o
b
e
si
ty
B
M
I
H
ig
h
B
P
,
h
ig
h
S
B
P
o
r
h
ig
h
D
B
P
S
B
P
D
B
P
H
y
p
e
rt
e
n
si
o
n
in
p
a
re
n
ts
O
th
e
r
P
re
se
n
ta
ti
o
n
o
f
fi
n
a
l
p
re
d
ic
ti
o
n
m
o
d
e
l(
s)
Fe
rr
er
et
al
.
(2
0
1
5
)
[1
7
]
C
la
ss
if
ic
at
io
n
tr
ee
s
u
si
n
g
th
e
ch
i-
sq
u
ar
e
au
to
m
at
ic
in
te
ra
ct
io
n
d
et
ec
ti
o
n
m
et
h
o
d
(C
H
A
ID
)
Se
le
ct
io
n
:
C
H
A
ID
Tr
ee
1
,
b
as
ed
o
n
ca
te
g
o
ri
ca
l
va
ri
ab
le
s
d
W
ai
st
ci
rc
u
m
fe
re
n
ce
>
9
0
th
p
er
ce
n
ti
le
Sm
o
ki
n
g
C
la
ss
if
ic
at
io
n
tr
ee
s
Tr
ee
2
,
b
as
ed
o
n
co
n
ti
n
u
o
u
s
va
ri
ab
le
s
W
ai
st
ci
rc
u
m
fe
re
n
ce
Tr
ee
3
,
b
as
ed
o
n
co
n
ti
n
u
o
u
s
va
ri
ab
le
s,
fo
r
m
al
es
W
ai
st
ci
rc
u
m
fe
re
n
ce
Tr
ee
4
,
b
as
ed
o
n
co
n
ti
n
u
o
u
s
va
ri
ab
le
s,
fo
r
fe
m
al
es
W
ai
st
ci
rc
u
m
fe
re
n
ce
Ju
h
o
la
et
al
.
(2
0
1
2
)
[1
9
]
Lo
g
is
ti
c
re
g
re
ss
io
n
Pr
es
el
ec
ti
o
n
:
A
g
e-
ad
ju
st
ed
an
d
se
x-
ad
ju
st
ed
an
al
ys
is
p
er
ca
n
d
id
at
e
p
re
d
ic
to
r;
si
g
n
if
ic
an
t
va
ri
ab
le
s
w
er
e
in
cl
u
d
ed
in
a
m
u
lt
iv
ar
ia
b
le
m
o
d
el
.
In
d
ep
en
d
en
t
p
re
d
ic
to
rs
in
th
is
m
u
lt
iv
ar
ia
b
le
an
al
ys
is
w
er
e
in
cl
u
d
ed
in
th
e
fi
n
al
m
o
d
el
s.
M
o
d
el
1
M
o
d
el
2
M
o
d
el
3
M
o
d
el
4
b b b
A
g
e
(m
o
d
el
1
–
2
–
3
-4
)
Se
x
(m
o
d
el
1
-2
-3
-4
)
R
es
ti
n
g
h
ea
rt
ra
te
Pa
re
n
ta
l
sm
o
ki
n
g
Pa
re
n
ta
l
ed
u
ca
ti
o
n
al
le
ve
l
Fa
m
ily
in
co
m
e
Pa
re
n
ta
l
o
cc
u
p
at
io
n
al
st
at
u
s
(m
o
d
el
2
-3
-4
)
Fr
u
it
/v
eg
et
ab
le
co
n
su
m
p
ti
o
n
M
ilk
co
n
su
m
p
ti
o
n
Ph
ys
ic
al
ac
ti
vi
ty
in
d
ex
Sm
o
ki
n
g
A
g
e
at
m
en
ar
ch
e
B
ir
th
w
ei
g
h
t
Pr
et
er
m
b
ir
th
Im
p
ai
re
d
fe
ta
l
g
ro
w
th
To
ta
l
ch
o
le
st
er
o
l
Tr
ig
ly
ce
ri
d
es
H
D
L
ch
o
le
st
er
o
l
LD
L
ch
o
le
st
er
o
l
In
su
lin
C
R
P
G
en
et
ic
ri
sk
sc
o
re
(m
o
d
el
3
-4
)
O
R
’s
fo
r
m
o
d
el
co
m
p
ar
ab
le
w
it
h
m
o
d
el
4
.
In
th
e
su
p
p
le
m
en
ta
l
in
fo
rm
at
io
n
a
ri
sk
sc
o
re
is
p
ro
vi
d
ed
d
er
iv
ed
fr
o
m
th
e
fu
ll
m
o
d
el
,
b
u
t
th
is
d
o
es
n
o
t
p
ro
vi
d
e
an
in
te
rc
ep
t.
N
o
p
re
d
ic
ti
o
n
o
f
in
d
iv
id
u
al
ab
so
lu
te
ri
sk
p
o
ss
ib
le
.
Ju
h
o
la
et
al
.
(2
0
1
1
)
[1
8
]
N
o
t
ex
p
lic
it
ly
m
en
ti
o
n
ed
,
co
u
ld
h
av
e
b
ee
n
p
er
fo
rm
ed
u
si
n
g
tw
o
-b
y-
tw
o
ta
b
le
s
(s
tr
at
if
ie
d
fo
r
se
x)
.
Se
le
ct
io
n
:
N
A
M
o
d
el
1
,
m
al
es
M
o
d
el
2
,
fe
m
al
es
d d
Ta
b
le
s
w
it
h
p
o
si
ti
ve
an
d
n
eg
at
iv
e
p
re
d
ic
ti
ve
va
lu
es
p
er
se
x
an
d
ag
e.
Hamoen et al.
870 www.jhypertension.com Volume 37  Number 5  May 2019
T
A
B
LE
2
(C
o
n
ti
n
u
e
d
)
(C
a
n
d
id
a
te
)
p
re
d
ic
to
rs
A
u
th
o
r
(y
e
a
r)
M
o
d
e
ll
in
g
m
e
th
o
d
a
n
d
m
e
th
o
d
fo
r
se
le
ct
io
n
o
f
p
re
d
ic
to
rs
M
o
d
e
ls
O
v
e
rw
e
ig
h
t/
o
b
e
si
ty
B
M
I
H
ig
h
B
P
,
h
ig
h
S
B
P
o
r
h
ig
h
D
B
P
S
B
P
D
B
P
H
y
p
e
rt
e
n
si
o
n
in
p
a
re
n
ts
O
th
e
r
P
re
se
n
ta
ti
o
n
o
f
fi
n
a
l
p
re
d
ic
ti
o
n
m
o
d
e
l(
s)
Li
et
al
.
(2
0
1
1
)
[2
1
]
R
O
C
an
al
ys
is
Se
le
ct
io
n
:
N
A
M
o
d
el
1
M
o
d
el
2
M
o
d
el
3
b c
Se
x
Se
x
Se
x
B
M
I
g
ai
n
N
o
p
ro
b
ab
ili
ti
es
re
p
o
rt
ed
,
n
o
in
d
iv
id
u
al
ri
sk
p
re
d
ic
ti
o
n
p
o
ss
ib
le
.
Su
n
et
al
.
(2
0
0
7
)
[2
2
]
Lo
g
is
ti
c
re
g
re
ss
io
n
Se
le
ct
io
n
:
N
A
M
o
d
el
1
,
m
al
es
M
o
d
el
2
,
fe
m
al
es
e e
A
g
e
at
fi
rs
t
d
ia
g
n
o
si
s
o
f
h
yp
er
te
n
si
o
n
A
g
e
at
fi
rs
t
d
ia
g
n
o
si
s
o
f
h
yp
er
te
n
si
o
n
R
eg
re
ss
io
n
eq
u
at
io
n
s
(b
u
t
o
n
e
p
re
d
ic
to
r
n
o
t
av
ai
la
b
le
fo
r
n
ew
in
d
iv
id
u
al
).
V
o
s
et
al
.
(2
0
0
3
)
[2
0
]
Lo
g
is
ti
c
re
g
re
ss
io
n
Se
le
ct
io
n
:
b
ac
kw
ar
d
se
le
ct
io
n
,
P
va
lu
e
fo
r
re
m
o
va
l
0
.1
0
M
o
d
el
1
,
b
o
th
g
en
d
er
s
M
o
d
el
2
,
m
al
es
M
o
d
el
3
,
fe
m
al
es
Se
x
A
g
e
A
g
e
A
g
e
O
R
s
o
n
ly
,
n
o
in
d
iv
id
u
al
ri
sk
p
re
d
ic
ti
o
n
p
o
ss
ib
le
.
B
P,
b
lo
o
d
p
re
ss
u
re
;
C
H
A
ID
,
ch
i-
sq
u
ar
e
au
to
m
at
ic
in
te
ra
ct
io
n
d
et
ec
ti
o
n
;
C
R
P,
C
-r
ea
ct
iv
e
p
ro
te
in
;
H
D
L,
h
ig
h
-d
en
si
ty
lip
o
p
ro
te
in
;
IO
TF
,
In
te
rn
at
io
n
al
O
b
es
it
y
Ta
sk
Fo
rc
e;
LD
L,
lo
w
-d
en
si
ty
lip
o
p
ro
te
in
;
N
A
,
n
o
t
ap
p
lic
ab
le
;
O
R
,
o
d
d
s
ra
ti
o
;
R
O
C
,
re
ce
iv
er
o
p
er
at
in
g
ch
ar
ac
te
ri
st
ic
.
,
in
cl
u
d
ed
as
ca
n
d
id
at
e
p
re
d
ic
to
r
b
u
t
n
o
t
se
le
ct
ed
as
p
re
d
ic
to
r
in
fi
n
al
m
o
d
el
.
,
p
re
d
ic
to
r
in
fi
n
al
m
o
d
el
.
a
D
et
ai
le
d
in
fo
rm
at
io
n
o
n
m
ea
su
re
m
en
ts
an
d
ex
ac
t
d
ef
in
it
io
n
s
o
f
ca
n
d
id
at
e
p
re
d
ic
to
rs
an
d
o
u
tc
o
m
es
is
p
re
se
n
te
d
in
Su
p
p
le
m
en
ta
l
Ta
b
le
3
,
h
tt
p
:/
/li
n
ks
.lw
w
.c
o
m
/H
JH
/B
3
2
.
b
O
ve
rw
ei
g
h
t/
o
b
es
it
y
ac
co
rd
in
g
to
IO
TF
cu
t-
o
ff
s.
c
O
ve
rw
ei
g
h
t/
o
b
es
it
y
ac
co
rd
in
g
to
st
u
d
y-
sp
ec
if
ic
cu
t-
o
ff
s.
d
SB
P
o
r
D
B
P
at
le
as
t
9
0
th
p
er
ce
n
ti
le
o
r
at
le
as
t
1
2
0
/8
0
m
m
H
g
(a
cc
o
rd
in
g
to
Fo
u
rt
h
R
ep
o
rt
)
[3
0
].
e
El
ev
at
ed
b
lo
o
d
p
re
ss
u
re
,
d
ef
in
ed
as
a
si
n
g
le
m
ea
n
el
ev
at
ed
SB
P
th
at
ex
ce
ed
ed
ag
e-
sp
ec
if
ic
an
d
se
x-
sp
ec
if
ic
cr
it
er
io
n
va
lu
es
d
er
iv
ed
in
fi
rs
t
p
ar
t
o
f
th
e
st
u
d
y.
Predicting hypertension: a review
Journal of Hypertensionstudy [17]. Continuous SBP and DBP were candidate pre-
dictors in three studies, and SBP was in at least one of the
final models in all three of these studies [17,19,20]. DBP was
only selected in the final model for girls in one study [17].
Other variables that were in a final model were: sex [17–
22], age [19,20], BMI gain [21], parental hypertension [19],
parental occupational status [19], and a genetic risk score
[19]. In one study, the predictor ‘age when adulthood
hypertension was first diagnosed’ was included [22], which
raised serious concerns about the quality and applicability
of the prediction models developed in this study. Most
importantly, the ‘age when adulthood hypertension was
first diagnosed’ would not be available in childhood, the
intended time point of use of the models, and implies an
unrealistic predictor that is based on outcome information.
This might explain why this predictor was so important, as
well as the high discriminative performance of the models.
Also, it remained unclear how this variable was dealt with
for participants who were not diagnosed with hypertension
during the follow-up.Time interval between prediction and outcome
In three studies, the time interval between prediction and
outcome was the same for all participants [17,18,21]. In one
of these studies this interval was 4 years [17], in the other
two studies, this interval was longer, namely 27 years [18]
and 38 years [21]. In two other studies, there was some
variation between participants in the time interval, ranging
from 21 to 27 years in one study [19], and on average from
15 to 21 years in the other study [20]. In another study,
participants were born between 1930 and 1983, but
whether hypertension had occurred was assessed at the
time of analysis, and therefore, follow-up durations differed
between participants [22]. Hence, older participants were
followed for a longer period of time, and would have been
more likely to have developed hypertension at the time of
analysis than younger participants. Therefore, themean age
of participants with hypertension was probably higher than
the age of those who had not developed hypertension. This
might also explain why ‘age at diagnosis of hypertension’
was such an important predictor in this study, although, as
mentioned before, we could not determine how this vari-
able was filled in for those participants who did not
develop hypertension.Sample size and number of events
Reported sample sizes for model development ranged from
252 [17] to 4497 [21] (Table 1). The number of events was
reported clearly in four studies [17,19,20,22], and the num-
ber of events-per-variable (ideally at least 10–15 events per
variable) [23] was adequate in three of them [19,20,22]. In
one study, the number of events was 47, whereas five to six
variables were considered [17], leading to less than 10
events per variable. In two studies, the number of events
was not clearly reported for the exact sample in which
the models were developed [18,21]. However, as these
studies had large sample sizes and their models were
developed based on two predictors, we consider it likely
that the number of events per variable was adequate in
these studies.www.jhypertension.com 871
Hamoen et al.Handling of missing data
The handling of missing values was reported clearly in only
one study; here missing values were imputed using multi-
ple imputation [21]. In the other studies, information on
the handling of missing data was lacking [17–20,22]; most
likely complete case analyses were performed in these
studies.
Modelling methods
Modelling methods are described in Table 2; they consisted
of multivariable logistic regression analysis (three studies)
[19,20,22], receiver operating characteristic (ROC) analysis
(one study) [21], stratified cross-tabulations (one study) [18],
and classification tree analysis (one study) [17]. In three of
the studies, a selection procedure was applied to select the
predictors for the final models from a broader range of
candidate predictors [17,19,20]. In one study, classification
trees were developed using the chi-square automatic inter-
action detection method [17]. One study selected predictors
using logistic regression with backward selection [20]. In
the other study, univariable preselection preceded the
multivariable analysis [17].
Validation
None of the models had been validated, neither internally
(e.g. using cross-validation or bootstrapping procedures)
nor externally.
Model performance
Results on model performance are presented in Table 3.
The area under ROC curve (AUCs) for the prediction
models was reported in four studies [19–22]. In one study,
in which models were developed by selecting from a broad
range of candidate predictors, AUCs ranged from 0.718 (for
the smallest model) to 0.742 (for themost extensive model).
In this study, the four models were also compared using the
net reclassification improvement and the integrative dis-
crimination index, which showed that the more extensive
the model, the better the discriminative performance [19].
AUCs of 0.74 were also reported in one other study, but
only for the overall model and the model for women (AUCs
of 0.74). The model stratified for men had a remarkably
lower AUC of 0.59 [20]. In one study, with models based
only on BMI and sex, the reported AUCs were low, ranging
from 0.51 to 0.54 [21]. One study reported very high AUCs,
ranging from 0.86 to 0.93 [22]. This may be explained by the
inclusion of ‘age at first diagnosis of hypertension’ as a
predictor, which, as mentioned previously, would not be
available at the intended time point of prediction, and is not
realistic for application in practice.
Sensitivity and specificity were reported in two studies
[18,21], and could be calculated from the trees in one study
[17]. There was wide variation in sensitivity (8.3–78.6%) and
specificity (25.7–96.1%). Positive and negative predictive
values (PPV and NPV) were only reported in one study, and
ranged from 10.9 to 51.4% for PPV and from 71.3 to 95.7%
for NPV [18]. In another study, PPV and NPV could be
derived from the classification trees; PPV ranged from 36.7
to 68.0% and NPV from 84.2 to 96.9%) [17]. Calibration and872 www.jhypertension.comexplained variation were reported in only one study, and
there was no indication that models were not adequately
calibrated (i.e. the Hosmer-Lemeshow P value was >0.05).
The explained variation for the most elaborate model was
22% [19].
Model presentation
In only two studies, models were presented in such a
way that it was possible to calculate a predicted risk for
a new individual child, either by following the steps in
the classification trees [17], or by using the reported age-
specific and sex-specific PPVs of the corresponding child-
hood risk factor [18]. One study presented a full regression
equation [22], but as the predictor ‘age at first diagnosis of
hypertension’ is naturally not available at the time point
of prediction, this model cannot be applied in a new
individual. Another study presented a regression equation
in the supplementary material, but without providing
the intercept, hampering the calculation of a predicted
risk [19].
Risk of bias assessment
Table 4 shows the results of the risk assessment for selection
bias, information bias, and bias related to the analysis in the
included studies. Two studies [17,22] scored ‘high’ for risk of
selection bias related to participant selection; for both
studies this was because of limited or unclear information
on recruitment and selection of the study population, and
because of limited information on key characteristics and
predictors for the study sample. For selection bias related to
sample attrition, all five prospective studies [17–19,21,22]
reported the amount of loss to follow-up, and four [17–
19,21] of these scored ‘moderate,’ as loss to follow-up was
higher than 20%. With regard to risk of information bias for
predictors, two studies [20,22] scored ‘high,’ which was
because of: unclear definitions/measurements of predictors
[20,22], possibly less valid and reproducible measurements
[20], lack of standardized measurements [20], different tim-
ing of predictor assessment within the study sample [22],
and/or unavailability of predictors at the intended time
point of use of the model [22]. For the risk of information
bias related to the outcome, four studies [17–19,22] scored
‘high,’ because of lack of information on blinding for
predictor information [17–19,22], unclear definitions of
outcome and measurement of outcome [17,22], possibly
less valid and reproducible measurements [17–19,22], and/
or different assessment (including timing) within the study
sample [18,19,22]. Lastly, for risk of bias related to the
analysis, four studies [17–19,22] scored ‘high’ and the other
two studies [20,21] ‘moderate.’ Continuous predictors were
sometimes categorized without this being part of the
research question [17,19], and missing values were often
not clearly reported and only complete cases seem to have
been included [18–20,22]. Furthermore, the number of
events per variable was too low in one study [17], and
unclear in another [18]. Most notably, as mentioned before,
none of the studies accounted for overfitting and optimism,
that is, no internal validation and/or external validation was
performed [17–22].Volume 37  Number 5  May 2019
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TABLE 4. Results of risk of bias assessment
Risk of biasa
Selection bias Information bias Other
Author (year) [ref] Selection of participants Sample attrition Predictors Outcome Analysis
Ferrer et al. (2015) [17] H M M H H
Juhola et al. (2012) [19] M M M H H
Juhola et al. (2011) [18] M M L H H
Li et al. (2011) [21] M M L M M
Sun et al. (2007) [22] H L H H H
Vos et al. (2003) [20] M NA H L M
H, high risk of bias; L, low risk of bias; M, moderate risk of bias; NA, not applicable (retrospective study).
aThe criteria that were used to perform this risk of bias assessment are shown in Supplemental Table 2, http://links.lww.com/HJH/B32.
Predicting hypertension: a reviewDISCUSSION
We identified six studies meeting the inclusion and exclu-
sion criteria, in which a total of 18 eligible models were
presented. These models predict, in childhood, the risk of
hypertension in later life, mostly in adulthood. However, no
studies were identified that aimed to translate the prediction
model into practice, which is reflected in the results of our
systematic review. First of all, in each study, multiple
combinations of predictors were investigated (e.g. age-
specific models and models comparing categorized and
continuous predictors), without presenting one final pre-
diction model as the one most optimal for use in clinical
practice, in a format that could be applied by others. Related
to this, in the majority of the included studies, the develop-
ment of models was based on a few predictors chosen a
priori, such as sex, BMI, overweight or earlier (high) blood
pressure. In fact, only one study considered a large number
of candidate predictors in order to find the best combina-
tion for the prediction model [19]. For clinical or public
health practice, it will possibly be more useful to have one
optimal prediction model incorporating information on all
of the most relevant predictors. Secondly, we saw that only
two out of six studies presented prediction models in a
format that would allow for application in new individuals
[17,18], and that in one study, a predictor was part of the
models that would not be available at the intended time
point of use [22]. Finally, the lack of attention for the
application in practice might also explain the limited infor-
mation on performance for most models, as well as the lack
of validation. Our results, therefore, underline the need for
further development and validation studies of childhood
prediction models for future hypertension, in order to pave
the way for early targeted primordial prevention.
The completeness of reporting varied across the
included studies. Inadequate reporting makes it more diffi-
cult to assess the quality of the prediction models, and to
draw conclusions about the reliability, validity and gener-
alizability of the prediction models [24]. We identified the
following important aspects related to reporting and to
model development that deserve attention. First of all,
sample selection procedures were not always described
clearly, and most studies dealt with loss to follow-up
whereas failing to report on differences in key character-
istics between the sample for analysis and the participants
that were lost to follow-up. Secondly, all studies had some
limitations with regard to the outcome assessment, such asJournal of Hypertensiondifferent follow-up durations for participants, and details
on blinding the outcome assessment were often lacking.
With regard to the quality of model development, in most
studies some aspects could be improved, such as the use of
continuous variables, the handling of missing values and
the prevention of overfitting (e.g. having an adequate
number of events per variable, and not performing uni-
variable preselection). Categorization of continuous varia-
bles can lead to a loss of predictive information, and should
ideally be avoided [25]. Performing a complete case analysis
instead of imputing missing values, might lead to a loss of
statistical power and to incorrect estimates of the predictive
performance of the model and the predictors [25].
For most models, the information about the perfor-
mance was very limited, making it difficult to evaluate
and compare the capability of the models to predict high
blood pressure in later life. A direct comparison was also
difficult because the prediction models in the different
studies were targeted at different age groups, and the
age at outcome assessment also varied widely. Further-
more, as none of the models was internally or externally
validated, and it cannot be determined how optimistic the
presented performance is, that is, how well these models
would perform in slightly different populations. The AUCs
reported in two studies (AUC 0.71–0.74) showed that
discrimination between children who did and who did
not have hypertension in adulthood was reasonable
[19,20]. These results support the idea that the develop-
ment of a reasonably performing predictionmodel for high
blood pressure might be possible.
A strength of this review is that we applied a compre-
hensive search strategy in both Medline and Embase, two
databases that together cover the majority of the medical
scientific literature. By hand searching the reference lists of
relevant reviews and the included studies, no new studies
were identified. We, therefore, consider it unlikely that we
have missed a relevant prediction modelling study for this
topic. Nevertheless, it should be noted that we restricted
our search to English publications, and although we did not
identify relevant non-English publications through hand
searching, we cannot fully exclude that we might have
missed studies on prediction models written in another
language. Another strength is that we used the CHARMS
checklist to systematically extract the data on key character-
istics of the study population, the model development, and
the final models. A limitation might be that, because of
the large amount of references identified with the searchwww.jhypertension.com 875
Hamoen et al.strategy, title and abstract screening was primarily per-
formed by one reviewer (M.H.). Two other reviewers
(M.K. and Y.V.) together checked a random 10% sample,
and as the agreement was over 99%, and the first reviewer
(M.H.) was being more inclusive of titles/abstracts, we
consider the selection to be adequate. Another limitation
could be that during data extraction, the two reviewers M.H.
and M.W. were not blinded for journal and author details.
However, both M.H. and M.W. do not have any affiliations
with any of the authors or journals and, therefore, we do not
believe it to have had any effect on the data extraction
and evaluation.
On the basis of the results of this review, we would
recommend to perform additional analyses (including vali-
dation and/or adaptation) on the existing models in order
to move towards implementation in practice, or the devel-
opment of a new model to identify children at high risk of
hypertension. When developing such a new model, it is
important to carefully choose the target age (or age range)
for application of the predictionmodel, the age for outcome
assessment, and the candidate predictors. For the latter, it
can be recommended to consider a broad range of candi-
date predictors (e.g. based on literature) if the sample size
and the number of events allow for it. On the basis of the
results of this systematic review, the following predictors
can be considered relevant: weight status, blood pressure,
parental hypertension, parental occupational status, sex,
and age. With regard to weight status, in the studies both
continuous measures (BMI) and categorized measures
(overweight/obesity) were used [17,19–22]. As dichotomi-
zation of continuous predictors can lead to a loss of valu-
able information [23,26], using BMI instead of overweight/
obesity is to be preferred. Moreover, in children it might be
better to use standardized measures of BMI, such as z-
scores or standard deviation scores relative to age and sex,
because of normal changes in BMI that occur as children
age [27]. For blood pressure, similar considerations are
important. For example, a continuous measure of blood
pressure, especially SBP, was shown to be amore important
predictor than childhood prehypertension, a dichotomized
predictor [19]. SBP might be more predictive of future
hypertension than DBP [17,19,20]. The use of blood pres-
sure standard deviation scores or percentiles (based on sex-
specific and age-specific reference values) as a continuous
variable might also be considered [18,28]. Parental occupa-
tional status was identified as a predictor in one of the
studies [19], but other socioeconomic indicators such as
parental educational level or income might also be relevant
[29]. Next, helpful methodological resources are available to
further improve prediction model development [23,25];
these discuss appropriate model selectionmethods, dealing
with missing values, and internal and external validation
methods. Also, it can be recommended to report the meth-
ods and results with help of the ‘Transparent Reporting of a
Multivariable Prediction Model for Individual Prognosis or
Diagnosis’ (TRIPOD) statement and the TRIPOD explana-
tion and elaboration document, in order to improve the
quality and transparency of reporting [24]. Lastly, it is
important that prediction models are presented in such a
way that they can be applied in new individuals by other
researchers or healthcare professionals interested in the876 www.jhypertension.commodel. This will also allow for external validation (by
others), which is essential to evaluate the generalizability
and applicability of a prediction model in other populations
than the study population.
In conclusion, several prediction models were identified
that predict, in childhood, the risk of hypertension in later
life, mostly in adulthood. Important predictors were weight
status (BMI or overweight/obesity), current high blood
pressure, SBP, DBP, sex, age, parental hypertension, and
socioeconomic status. In general, the quality of reporting
and model development was suboptimal, and as none of
the identified models were validated, it is not possible to
assess their value for practice and to recommend the use of
any of these models. Because of the lack of validation, the
reported estimates of the performance are likely to be too
optimistic. The results of this review indicate that there is
some potential for a prediction model for future hyperten-
sion based on multiple characteristics in childhood.ACKNOWLEDGEMENTS
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